DICOM PS3.17 2021d - Explanatory Information

WWWW.5 Complete Prostate Imaging Report SR Document (Current)
Prev | WWWW Prostate Imaging Report SR Document |

## WWWW.5 Complete Prostate Imaging Report SR Document

This example contains all of the components for a complete report.

Table WWWW.5-1. Complete Prostate Imaging Report SR Document

Node | Code Meaning of Concept Name | Code Meaning or Example Value | TID
--- | --- | --- | ---
1 | Multiparametric magnetic resonance imaging of prostate |  | TID 4300
1.1 | Language of Content Item and Descendants | English | TID 1204
1.2 | Observer Type | Person | TID 1001
1.3 | Person Observer Name | Smith^John | TID 1003
1.4 | Subject name | Jackson^Paul | TID 1007
1.5 | Subject ID | S98765432 | TID 1007
1.6 | Reporting System | PI-RADS v2.0 | TID 4300
1.7 | Image Library |  | TID 1600
1.7.1 | Image Library Group |  | TID 1600
1.7.1.1 | Modality | MR | TID 1602
1.7.1.2 | Magnetic field strength | 3 T | TID 1606
1.4.1.3 | MR coil | Endorectal | TID 1606 CID 6349
1.7.1.4 | MR signal intensity | T2 Weighted MR Signal Intensity | TID 1606 CID 6311
1.7.1.5 | Cross-sectional scan plane orientation | Axial | TID 1606 CID 6312
1.7.1.6 | IMAGE |  | TID 1601
1.7.1.n | IMAGE |  | TID 1601
1.7.2 | Image Library Group |  | TID 1600
1.7.2.1 | Modality | MR | TID 1602
1.7.2.2 | Magnetic field strength | 3 T | TID 1606
1.7.2.3 | MR coil | Endorectal | TID 1606 CID 6349
1.7.2.4 | MR signal intensity | Diffusion weighted | TID 1606 CID 6311
1.7.2.5 | Cross-sectional scan plane orientation | Axial | TID 1606 CID 6312
1.7.2.6 | Source image diffusion b-value | 50 s/mm2 | TID 1606
1.7.2.7 | Source image diffusion b-value | 400 s/mm2 | TID 1606
1.7.2.8 | Source image diffusion b-value | 800 s/mm2 | TID 1606
1.7.2.9 | Source image diffusion b-value | 1400 s/mm2 | TID 1606
1.7.2.7 | IMAGE |  | TID 1601
1.7.2.n | IMAGE |  | TID 1601
1.7.3 | Image Library Group |  | TID 1600
1.7.3.1 | Modality | MR | TID 1602
1.7.3.2 | Magnetic field strength | 3 T | TID 1606
1.7.3.3 | MR coil | Endorectal | TID 1606 CID 6349
1.7.3.4 | MR signal intensity | Dynamic Contrast-Enhanced Acquisition | TID 1606 CID 6311
1.7.3.5 | Cross-sectional scan plane orientation | Axial | TID 1606 CID 6312
1.7.3.6 | Prostate DCE temporal resolution | 10 s | TID 1608
1.7.3.7 | IMAGE |  | TID 1601
1.7.3.n | IMAGE |  | TID 1601
1.8 | General Relevant Patient Information |  | TID 9007 CID 6327
1.8.1.1 | Indicated Problem | Elevated Prostate Specific Antigen | TID 9007 CID 6327
1.8.2 | Genitourinary History |  | TID 4301
1.8.2.1 | Diagnostic procedure |  | TID 4301
1.8.2.1.1 | Blood lab measurements |  | TID 1700 CID 6352
1.8.2.1.1.1 | Sampling DateTime | 19860101120101-0400 | TID 1700
1.8.2.1.1.2 | Prostate Cancer Antigen Measurement | 12.1 ng/mL | TID 1700 TID 300
1.9 | Prostate MRI relevant procedure information |  | TID 4300
1.9.1 | Contrast administered | Gadobutrol | TID 3106 CID 3409 CID 12
1.9.1.1 | Route of administration | Intra-arterial route | TID 3106 CID 11
1.9.1.2 | Volume administered | 10 mL | TID 3106 CID 3410
1.9.1.3 | Rate of administration | 2 ml/s | TID 3106 CID 3410
1.9.2 | Endorectal coil used | No | TID 4300 CID 231
1.10 | Imaging study quality |  | TID 1701
1.10.1 | Quality Assessment | Usable - Meets the quality control standard | TID 1701 CID 6044
1.10.2 | Quality Control Standard | PI-RADS 2.0 prostate MRI acquisition requirements | TID 1701 CID 6353
1.10.3 | Imaging Series Quality |  | TID 1701
1.10.3.1 | Series Instance UID |  | TID 1701
1.10.3.2 | Quality Assessment | Usable - Meets the quality control standard | TID 1701 CID 6044
1.10.3.3 | Quality Control Standard | Institutionally defined quality control standard | TID 1701 CID 6326
1.10.3.4 | Quality Finding | Distortion artifact in the area of interest | TID 1701 CID 6318
1.11 | Prostate Imaging Findings |  | TID 4302
1.11.1 | Overall Prostate Finding |  | TID 4303
1.11.1.1 | Tracking Identifier | "Prostate" | TID 4303
1.11.1.2 | Tracking Unique Identifier | 2.999.1 | TID 4303
1.11.1.3 | Finding | Entire | TID 4303
1.11.1.4 | Finding site | Prostate | TID 4303
1.11.1.5 | Measurement Group |  | TID 1501
1.11.1.5.1 | Height | 5 mm | TID 300 CID 7470
1.11.1.5.1.1 | Source | SCOORD GraphicType POLYLINE with two coordinates, the beginning and end of a line segment | TID 320
1.11.1.5.1.1.1 | (none) | IMAGE - MR image #1 | TID 320
1.11.1.5.2 | Width | 4 mm | TID 300 CID 7470
1.11.1.5.2.1 | Source of Measurement | SCOORD GraphicType POLYLINE with two coordinates, the beginning and end of a line segment | TID 320
1.11.1.5.2.1.1 | (none) | IMAGE - MR image #2 | TID 320
1.11.1.5.3 | Length | 4 mm | TID 300 CID 7470
1.11.1.5.3.1 | Source | SCOORD GraphicType POLYLINE with two coordinates, the beginning and end of a line segment | TID 320
1.11.1.5.3.1.1 | (none) | IMAGE - MR image #3 | TID 320
1.11.1.6 | Peripheral zone |  | TID 4303 CID 6300
1.11.1.6.1 | Signal characteristics | Heterogeneous | TID 4303 CID 6334 CID 6344
1.11.1.6.2 | Signal characteristics | Slightly heterogeneous high signal | TID 4303 CID 6334
1.11.1.7 | Transition zone |  | TID 4303 CID 6300
1.11.1.7.1 | Signal characteristics | Heterogeneous | TID 4303 CID 6334 CID 6344
1.11.2 | Localized Prostate Finding |  | TID 4304
1.11.2.1 | Tracking Identifier | "Lesion 1" | TID 4304
1.11.2.2 | Tracking Unique Identifier | 2.999.2 | TID 4304
1.11.2.3 | Finding | Index lesion | TID 4304 CID 6337
1.11.2.4 | Finding Site | Right anterior middle peripheral zone of prostate | TID 4304 CID 6300
1.11.2.5 | Measurement Group |  | TID 1501
1.11.2.5.1.1 | Length | 1.1 cm | TID 300 CID 7470
1.11.2.5.1.1.1 | Source | SCOORD GraphicType POLYLINE with two coordinates, the beginning and end of a line segment | TID 300
1.11.2.5.1.1.1.1 | (none) | IMAGE - MR image #4 | TID 1410
1.11.2.6 | PI-RADS Localized Abnormality Assessment |  | TID 4306
1.11.2.6.1 | Index Lesion | Yes | TID 4306 CID 231
1.11.2.6.2 | PI-RADS T2WI Lesion Assessment |  | TID 4306
1.11.2.6.2.1 | PI-RADS T2WI Lesion Assessment Category | PI-RADS 5 - T2WI PZ Very high | TID 4306 CID 6329
1.11.2.6.2.2 | Signal characteristics | Homogeneous | TID 4306 ???? ????
1.11.2.6.2.3 | Signal characteristics | Hypointense | TID 4306 ???? ????
1.11.2.6.3 | PI-RADS DWI Lesion Assessment |  | TID 4306
1.11.2.6.3.1 | PI-RADS DWI Lesion Assessment Category | PI-RADS 5 - DWI Very high | TID 4306 CID 6331
1.11.2.6.3.2 | Signal characteristics | Hyperintense | TID 4306 ???? ????
1.11.2.6.3.3 | Status of extraprostatic extension of nodal tumor | Present | TID 4306 ???? ????
1.11.2.6.4 | PI-RADS DCE Lesion Assessment |  | TID 4306
1.11.2.6.4.1 | PI-RADS DCE Lesion Assessment Category | PI-RADS DCE +ve | TID 4306 CID 6332
1.11.2.6.5 | PI-RADS Lesion Assessment Category | PI-RADS 5 - Very high (lesion) | TID 4306 CID 6328
1.11.3 | PI-RADS Overall Assessment Category | PI-RADS 5 - Very high | TID 4302 CID 6325

Prev | Up |
WWWW.4 Prostate MRI relevant patient information | Home |

DICOM PS3.17 2021d - Explanatory Information